Clinical Trials Logo

Clinical Trial Summary

The aim of this study is to see if administering platelets (cells in our blood that stop or prevent bleeding) results in improved platelet function and slows/stops the progression of a head bleed for patients who have a traumatic head bleed and are on antiplatelet therapy (medications that stop blood cells from forming a blood clot) prior to admission.


Clinical Trial Description

This study aims to determine if platelet function has improved following platelet transfusion by prospectively performing repeat thromboelastographic with platelet mapping (TEG-PM) assays on all patients consented and enrolled in the study. This study will also examine the rate of progression or stability of ICH on repeat head CT following platelet administration and will aid in the determination of a potential association between repeat CT head findings and the repeat TEG-PM results. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06433622
Study type Observational
Source Lancaster General Hospital
Contact
Status Enrolling by invitation
Phase
Start date December 1, 2023
Completion date November 2027

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05000060 - Restart TICrH AP Pilot Trial Phase 3
Completed NCT05609721 - Mild Traumatic Brain Injury and the Risk for Traumatic Intracranial Hemorrhage
Completed NCT05609734 - No Cases of Delayed Intracranial Hemorrhage (d-ICH) Among Patients With Mild Traumatic Brain Injury (mTBI) on Oral Anticoagulation Therapy
Completed NCT02728908 - Detecting Traumatic Intracranial Hemorrhage With Microwave Technology N/A